% Expired Patents = 100.0

EPO Patents = 1

Forward Citations = 37

Loading Chart...

12 inventors (with patents filed for the assignee):

Nitin Sharadchandra Pradhan (2 out of 2 patents)

Nilesh Sudhir Patil (2 out of 2 patents)

Nilesh Subhas Kulkarni (2 out of 2 patents)

4. Rajesh Ramchandra Walavalkar (2 out of 2 patents)

5. Sandip Babanrao Pawar (2 out of 2 patents)

6. Tarak Sambhaji Pawar (2 out of 2 patents)

7. Shankar Sanganabhatla (1 out of 2 patents)

8. Shankar Sanganbhatla (1 out of 1 patent)

9. Jitendra Pandurang Suryavanshi (1 out of 1 patent)

10. Alam Sayyed Zahid (1 out of 1 patent)

11. Sunanda Manoj (1 out of 1 patent)

12. Ramanarasimha Moorthy Koduru (1 out of 1 patent)

13. Mr Sandip Babanrao Pawar Pawar (0 patent)

14. Mr Nilesh Subhas Kulkarni Kulkarni (0 patent)

15. Dr Nilesh Sudhir Patil Patil (0 patent)

4 patents: Sort by Forward Citations

1. 9394292 - Rivaroxaban intermediate and preparation thereof (2016-07-19),

2. 9359341 - Aldehyde derivative of substitute oxazolidinones (2016-06-07),

3. 7777053 - Efficient process for production of carvedilol phosphate (2010-08-17),

4. 7763645 - Carvedilol dihydrogen phosphate monohydrate (2010-07-27),

Wanbury Limited is a pharmaceutical company based in India, with a focus on developing and manufacturing high-quality generic drugs and active pharmaceutical ingredients. With a strong presence in domestic and international markets, Wanbury is committed to providing affordable healthcare solutions that meet the highest standards of quality and safety. The company's vision is to become a leading player in the global pharmaceutical industry through innovation, excellence, and sustainability.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

4 Patents

#3 in Navi-Mumbai

#375 in India

Navi-Mumbai, India

Wanbury Limited